symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
PVTTF,0.0018,-986.99274,0,172430,0,1.0E-4-0.0021,0,Pivotal Therapeutics Inc.,USD,,,,Other OTC,PNK,Drug Manufacturersâ€”Specialty & Generic,https://www.pivotaltherapeutics.us,"Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.",Ms. Rachelle  MacSweeney,Healthcare,CA,,905-856-9797,81 Zenway Boulevard,Woodbridge,ON,L4H 0S5,,0,https://financialmodelingprep.com/image-stock/PVTTF.png,2012-03-27,True,False,False,False,False
